policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Therapeutic pet food health claims
The FDA uses enforcement discretion in overseeing certain pet food claims. While many of these could legally be considered drugs, certain claims are…
policy
Foot and mouth disease
Foot-and-mouth disease (FMD) is a severe, highly contagious viral disease of worldwide concern. View AVMA's recommendations for FMD preparedness and…
policy
UNDER REVIEWAABP judicious therapeutic use of antimicrobials in cattle
The AVMA has endorsed these guidelines developed by the American Association of Bovine Practitioners.
policy
Joint AVMA-FVE-CVMA statement on the benefits of animal vaccination programs in advancing animal and human health
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.
policy
Model bill and regulations to assure appropriate care for dogs intended for use as pets
This resource can serve as a guide for legislators and other government officials involved in developing legislation and regulations to assure…